Clin2
NCT07331935Possibly a fitRecruiting

Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia

Oral Leukoplakia

Treatments studied

Part of Cancer, Mouth & dental clinical trials.

This study tests whether a cream containing coenzyme Q10 and curcumin can help treat a common mouth condition called oral leukoplakia (a white patch that can sometimes turn into cancer). It is for people with a specific type of white patch that is not severe and can be easily reached with a cream.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
34 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You must have a white patch inside your mouth (called oral leukoplakia) that is not cancerous or severely abnormal.
  • The lesion must be in a spot where a cream can be applied directly.
  • You cannot have taken any antioxidant supplements like coenzyme Q10, curcumin, or vitamin E in the last 4 weeks.
  • You must not be pregnant or breastfeeding.
  • You must agree to follow the study schedule and return for check-ups.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07387900Recruiting· Phase 2
Metformin for preventing cancer in oral leukoplakia

This study tests if metformin — a medication commonly used for diabetes — can prevent oral leukoplakia from turning into cancer when applied as a mouth rinse and taken as a pill. It is for people with non-severe white patches in the mouth.

Cairo
NCT07453472Not yet recruiting· Phase 3
Light therapy vs vitamin D cream for oral leukoplakia

This study compares two topical treatments for oral leukoplakia, a white patch in the mouth that can become cancer. One treatment uses light-activated therapy (photodynamic therapy), and the other uses a vitamin D cream (calcipotriol).

New Delhi, National Capital Territory of Delhi
NCT03975322Recruiting
Predict which oral white patches may turn cancerous

This study looks at oral leukoplakia (persistent white patches in the mouth) to better predict which ones may develop into cancer. It uses a test based on specific immune and cancer-related markers to help estimate each person’s risk.

Erlangen
NCT06876038Not yet recruiting· Phase 2
Light therapy for early mouth lesions

This trial tests a low-cost light therapy to treat precancerous mouth lesions (moderate to severe dysplasia or carcinoma in situ) that are at least 10 mm. The treatment uses a special light to destroy abnormal cells, possibly avoiding surgery.

Ernākulam, Kerala
NCT05727761Recruiting· Phase 2
Pioglitazone plus metformin for high-risk mouth lesions

This trial studies whether a two-medicine diabetes drug combination can reduce or control risky early changes in certain mouth and throat lesions. You may be asked for small tissue samples (biopsies) before and after 12 weeks to see how the lesions respond.

Minneapolis, Minnesota
NCT06981767Recruiting· Phase 2
Bromelain vs. Steroids for Oral Lichen Planus

This trial tests whether a pineapple enzyme (bromelain) works as well as a standard steroid treatment for painful mouth sores caused by oral lichen planus. If you have this condition and are not taking other medications, you may be eligible.

Cairo, Cairo Governorate

Hear when a new Oral Leukoplakia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.